| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.50e-06 | 27 | 63 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.13e-05 | 57 | 63 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.84e-05 | 60 | 63 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.27e-05 | 65 | 63 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.27e-05 | 65 | 63 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 9.24e-05 | 75 | 63 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | glutathione peroxidase activity | 9.27e-05 | 28 | 63 | 3 | GO:0004602 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.02e-04 | 77 | 63 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 1.46e-04 | 6 | 63 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 2.04e-04 | 7 | 63 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.81e-04 | 100 | 63 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | selenium binding | 4.34e-04 | 10 | 63 | 2 | GO:0008430 | |
| GeneOntologyMolecularFunction | peroxidase activity | 1.14e-03 | 65 | 63 | 3 | GO:0004601 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on peroxide as acceptor | 1.24e-03 | 67 | 63 | 3 | GO:0016684 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.29e-03 | 17 | 63 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.45e-03 | 18 | 63 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.37e-03 | 23 | 63 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.59e-03 | 24 | 63 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 2.71e-03 | 766 | 63 | 8 | GO:0016491 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.17e-03 | 93 | 63 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.23e-03 | 193 | 63 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.48e-03 | 197 | 63 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | antioxidant activity | 3.57e-03 | 97 | 63 | 3 | GO:0016209 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 7.08e-06 | 157 | 62 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | glutamatergic synapse | NPTN BIN1 SPTBN1 DPYSL5 APC ARC GRID1 GRID2 GRIK1 GRIK2 NRP1 | 2.50e-05 | 817 | 62 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.88e-05 | 201 | 62 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | sodium channel complex | 8.59e-05 | 29 | 62 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.29e-04 | 6 | 62 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.91e-04 | 405 | 62 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | dendrite | 1.99e-04 | 858 | 62 | 10 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 2.03e-04 | 860 | 62 | 10 | GO:0097447 | |
| GeneOntologyCellularComponent | spectrin | 3.07e-04 | 9 | 62 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 3.23e-04 | 45 | 62 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.49e-04 | 317 | 62 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.67e-04 | 451 | 62 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 4.41e-04 | 50 | 62 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.13e-04 | 477 | 62 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | cytoplasmic region | 6.83e-04 | 360 | 62 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 7.02e-04 | 503 | 62 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynapse | 7.69e-04 | 1018 | 62 | 10 | GO:0098794 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 8.78e-04 | 1228 | 62 | 11 | GO:0036477 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 8.82e-04 | 523 | 62 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | axon | 1.19e-03 | 891 | 62 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.65e-03 | 583 | 62 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | distal axon | 1.80e-03 | 435 | 62 | 6 | GO:0150034 | |
| GeneOntologyCellularComponent | M band | 3.81e-03 | 31 | 62 | 2 | GO:0031430 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 4.28e-03 | 110 | 62 | 3 | GO:0120111 | |
| GeneOntologyCellularComponent | cell cortex | 4.85e-03 | 371 | 62 | 5 | GO:0005938 | |
| GeneOntologyCellularComponent | neuron projection terminus | 5.06e-03 | 233 | 62 | 4 | GO:0044306 | |
| Domain | Iontro_rcpt | 3.25e-07 | 18 | 62 | 4 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 3.25e-07 | 18 | 62 | 4 | PF10613 | |
| Domain | Iono_rcpt_met | 3.25e-07 | 18 | 62 | 4 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.25e-07 | 18 | 62 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.25e-07 | 18 | 62 | 4 | SM00918 | |
| Domain | Lig_chan | 3.25e-07 | 18 | 62 | 4 | PF00060 | |
| Domain | PBPe | 3.25e-07 | 18 | 62 | 4 | SM00079 | |
| Domain | GPX_AS | 1.21e-06 | 7 | 62 | 3 | IPR029759 | |
| Domain | GLUTATHIONE_PEROXID_2 | 1.93e-06 | 8 | 62 | 3 | PS00763 | |
| Domain | GLUTATHIONE_PEROXID_1 | 1.93e-06 | 8 | 62 | 3 | PS00460 | |
| Domain | Glutathione_peroxidase | 1.93e-06 | 8 | 62 | 3 | IPR000889 | |
| Domain | GLUTATHIONE_PEROXID_3 | 1.93e-06 | 8 | 62 | 3 | PS51355 | |
| Domain | GPX_CS | 1.93e-06 | 8 | 62 | 3 | IPR029760 | |
| Domain | GSHPx | 1.93e-06 | 8 | 62 | 3 | PF00255 | |
| Domain | ANF_lig-bd_rcpt | 6.70e-06 | 37 | 62 | 4 | IPR001828 | |
| Domain | ANF_receptor | 6.70e-06 | 37 | 62 | 4 | PF01094 | |
| Domain | Peripla_BP_I | 8.30e-06 | 39 | 62 | 4 | IPR028082 | |
| Domain | PH_dom-spectrin-type | 3.85e-04 | 9 | 62 | 2 | IPR001605 | |
| Domain | Actinin_actin-bd_CS | 2.62e-03 | 23 | 62 | 2 | IPR001589 | |
| Domain | Spectrin | 2.62e-03 | 23 | 62 | 2 | PF00435 | |
| Domain | ACTININ_2 | 2.62e-03 | 23 | 62 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.62e-03 | 23 | 62 | 2 | PS00019 | |
| Domain | Spectrin_repeat | 4.16e-03 | 29 | 62 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 5.04e-03 | 32 | 62 | 2 | IPR018159 | |
| Domain | SPEC | 5.04e-03 | 32 | 62 | 2 | SM00150 | |
| Domain | - | 6.01e-03 | 35 | 62 | 2 | 3.20.20.80 | |
| Domain | PH | 7.05e-03 | 229 | 62 | 4 | PF00169 | |
| Domain | Glyco_hydro_catalytic_dom | 7.06e-03 | 38 | 62 | 2 | IPR013781 | |
| Domain | - | 7.26e-03 | 119 | 62 | 3 | 3.40.50.1820 | |
| Pathway | WP_SELENIUM_MICRONUTRIENT_NETWORK | 1.28e-06 | 23 | 51 | 4 | MM15979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS | 7.21e-06 | 11 | 51 | 3 | M47926 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 4.15e-05 | 19 | 51 | 3 | M41732 | |
| Pathway | WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS | 4.20e-05 | 54 | 51 | 4 | MM15848 | |
| Pathway | WP_FOLIC_ACID_NETWORK | 6.54e-05 | 22 | 51 | 3 | MM15955 | |
| Pathway | WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS | 9.84e-05 | 67 | 51 | 4 | M39710 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 1.37e-04 | 28 | 51 | 3 | M41724 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 2.66e-04 | 7 | 51 | 2 | M27953 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.44e-04 | 38 | 51 | 3 | MM14969 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.67e-04 | 10 | 51 | 2 | MM15112 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 5.67e-04 | 10 | 51 | 2 | M41731 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 5.67e-04 | 10 | 51 | 2 | M10272 | |
| Pathway | WP_SELENIUM_METABOLISM_SELENOPROTEINS | 5.69e-04 | 45 | 51 | 3 | MM15877 | |
| Pubmed | HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. | 1.97e-07 | 7 | 63 | 3 | 15910762 | |
| Pubmed | 1.97e-07 | 7 | 63 | 3 | 11368344 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 10652368 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 9501919 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 34100982 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.60e-06 | 13 | 63 | 3 | 20859245 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.20e-06 | 497 | 63 | 8 | 36774506 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 12947409 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15673679 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24377578 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11182092 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 3.23e-06 | 2 | 63 | 2 | 15928066 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 14724198 | ||
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 3.23e-06 | 2 | 63 | 2 | 8700852 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15539395 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 37944084 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 7696618 | ||
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 3.23e-06 | 2 | 63 | 2 | 16221857 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 16219388 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 3.23e-06 | 2 | 63 | 2 | 8260617 | |
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 3.23e-06 | 2 | 63 | 2 | 15014126 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 23201771 | ||
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 3.23e-06 | 2 | 63 | 2 | 15537878 | |
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 3.23e-06 | 2 | 63 | 2 | 11144357 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 25043179 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 31625608 | ||
| Pubmed | GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons. | 3.23e-06 | 2 | 63 | 2 | 28696429 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15358807 | ||
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 3.23e-06 | 2 | 63 | 2 | 24760837 | |
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 3.23e-06 | 2 | 63 | 2 | 15483117 | |
| Pubmed | Glutamate receptors of the delta family are widely expressed in the adult brain. | 3.23e-06 | 2 | 63 | 2 | 25001082 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 3.23e-06 | 2 | 63 | 2 | 11985817 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11069933 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 9736607 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 10234023 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 15509753 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20303587 | ||
| Pubmed | Identification of rat EMAP, a delta-glutamate receptor binding protein. | 9.68e-06 | 3 | 63 | 2 | 11829466 | |
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 9.68e-06 | 3 | 63 | 2 | 27346345 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 1379666 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 8730589 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 28298473 | ||
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 9.68e-06 | 3 | 63 | 2 | 9880586 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 31513786 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 9.68e-06 | 3 | 63 | 2 | 15805114 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 25231404 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 26112936 | ||
| Pubmed | RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. | 9.68e-06 | 3 | 63 | 2 | 7523595 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 8287691 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.27e-05 | 25 | 63 | 3 | 8493579 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 17650106 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 26277340 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 24872547 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 10036185 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 16354929 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 25556835 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 15513934 | ||
| Pubmed | Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. | 1.93e-05 | 4 | 63 | 2 | 20081851 | |
| Pubmed | Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling. | 1.93e-05 | 4 | 63 | 2 | 12093729 | |
| Pubmed | Structural basis for integration of GluD receptors within synaptic organizer complexes. | 1.93e-05 | 4 | 63 | 2 | 27418511 | |
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 1.93e-05 | 4 | 63 | 2 | 30241548 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18782777 | ||
| Pubmed | Sex-specific perinatal expression of glutathione peroxidases during mouse lung development. | 1.93e-05 | 4 | 63 | 2 | 22326323 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 19369569 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 19161995 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 17174564 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 3.22e-05 | 5 | 63 | 2 | 23076118 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 28228252 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 3.22e-05 | 5 | 63 | 2 | 1717158 | |
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 3.22e-05 | 5 | 63 | 2 | 9593973 | |
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 3.22e-05 | 5 | 63 | 2 | 18793656 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 12223554 | ||
| Pubmed | Heteromer formation of delta2 glutamate receptors with AMPA or kainate receptors. | 3.22e-05 | 5 | 63 | 2 | 12573530 | |
| Pubmed | KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. | 3.22e-05 | 5 | 63 | 2 | 30905761 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 28854365 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 22025255 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 18358623 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 3.22e-05 | 5 | 63 | 2 | 29058671 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 28057765 | ||
| Pubmed | Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. | 4.82e-05 | 6 | 63 | 2 | 18483336 | |
| Pubmed | Neto1 is an auxiliary subunit of native synaptic kainate receptors. | 4.82e-05 | 6 | 63 | 2 | 21734292 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 12597860 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 17244534 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 4.82e-05 | 6 | 63 | 2 | 28714086 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 18647389 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 6.23e-05 | 974 | 63 | 9 | 28675297 | |
| Pubmed | Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. | 6.74e-05 | 7 | 63 | 2 | 12558988 | |
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 17428973 | ||
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 6.74e-05 | 7 | 63 | 2 | 9016303 | |
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 19342380 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 6.74e-05 | 7 | 63 | 2 | 9651535 | |
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 1310861 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 10602027 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 16445905 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 8.98e-05 | 8 | 63 | 2 | 8163463 | |
| Pubmed | GluD1 is a signal transduction device disguised as an ionotropic receptor. | 8.98e-05 | 8 | 63 | 2 | 34135511 | |
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 12372286 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 1.15e-04 | 9 | 63 | 2 | 9051806 | |
| Pubmed | 1.39e-04 | 55 | 63 | 3 | 22581228 | ||
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 1.44e-04 | 10 | 63 | 2 | 36653359 | |
| Interaction | GRIK5 interactions | 3.79e-07 | 20 | 62 | 4 | int:GRIK5 | |
| Cytoband | 10q22 | 2.80e-04 | 18 | 63 | 2 | 10q22 | |
| GeneFamily | Glutamate ionotropic receptor delta type subunits | 5.27e-06 | 2 | 42 | 2 | 1202 | |
| GeneFamily | Selenoproteins | 2.59e-05 | 25 | 42 | 3 | 890 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 5.24e-05 | 5 | 42 | 2 | 1199 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.10e-04 | 7 | 42 | 2 | 1113 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 1.71e-06 | 151 | 63 | 6 | M8901 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 2.15e-06 | 157 | 63 | 6 | MM1099 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-07 | 187 | 63 | 6 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-07 | 193 | 63 | 6 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-07 | 193 | 63 | 6 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.94e-07 | 200 | 63 | 6 | 5f1de1f9305e1784c12d526f6c8bdd7d56229f9b | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 162 | 63 | 5 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 5.65e-06 | 180 | 63 | 5 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 180 | 63 | 5 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 180 | 63 | 5 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 180 | 63 | 5 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.45e-06 | 185 | 63 | 5 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 187 | 63 | 5 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 187 | 63 | 5 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 188 | 63 | 5 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 188 | 63 | 5 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 190 | 63 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 190 | 63 | 5 | e2481bd5166fde2cdc0c3824894f2bccb8294fdd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-06 | 193 | 63 | 5 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-06 | 193 | 63 | 5 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-06 | 193 | 63 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-06 | 193 | 63 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 8.75e-06 | 197 | 63 | 5 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.41e-06 | 200 | 63 | 5 | 7b3284bf0000e14f5a51e4422231e5639a184579 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.41e-06 | 200 | 63 | 5 | e957f5926675f6c29208cfc3203a19dab538df38 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.41e-06 | 200 | 63 | 5 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.41e-06 | 200 | 63 | 5 | 2ea33ac1970791e6a601ac1e407ef32e4833792d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.41e-06 | 200 | 63 | 5 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.91e-05 | 134 | 63 | 4 | 6d97fa07f55ae20c17b9d5262e893957cccc6dba | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 140 | 63 | 4 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 140 | 63 | 4 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 140 | 63 | 4 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.72e-05 | 154 | 63 | 4 | 44d4d99b08216c0901e3bc32743fa0a8b85b5149 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.06e-05 | 156 | 63 | 4 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | Control-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.24e-05 | 157 | 63 | 4 | 4803f601c1ba43260aa09172acc7964aac2c8ccf | |
| ToppCell | Control-B_naive-12|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.42e-05 | 158 | 63 | 4 | 41318f864770370ce77ed3fa4a84f76c0c22c482 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 160 | 63 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 160 | 63 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.37e-05 | 163 | 63 | 4 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 164 | 63 | 4 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.78e-05 | 165 | 63 | 4 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L3-5_FEZF2_DCN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.78e-05 | 165 | 63 | 4 | aad0ab96d9d4387edfcef2b114346a030eb4b021 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.78e-05 | 165 | 63 | 4 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-05 | 165 | 63 | 4 | 7fe24be5bae7f0344243fb06cdfa02b4ddbb5a19 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-05 | 166 | 63 | 4 | 4b63ecedf21285974f0d188979fcdced27bf9ef9 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-05 | 166 | 63 | 4 | d6d29b0dc1ef471b1227495f349963ab37f22ec4 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 172 | 63 | 4 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.03e-04 | 172 | 63 | 4 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-04 | 175 | 63 | 4 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | facs-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 177 | 63 | 4 | 7f58286fc8797e9bdcf8ece0849f55680905955d | |
| ToppCell | facs-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 177 | 63 | 4 | d4cd54c07f1e51b5485270348fb7195d53465027 | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-04 | 178 | 63 | 4 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 179 | 63 | 4 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 180 | 63 | 4 | 2b2c656d6620afa32555f14aad94ac56e71e360c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 181 | 63 | 4 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.25e-04 | 181 | 63 | 4 | 1cfb03eb03a37b036b4eeacec69c9b8163af1ee4 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 182 | 63 | 4 | 6d7ba2e1f33aaa499a898ed9587197c0ee625e9a | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.31e-04 | 183 | 63 | 4 | bd78e5c2670e67b4363078e3ca5a5b7081d24b7e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 183 | 63 | 4 | 03c7e69136d5a3b9c5b2c91733e9b1c791f45c49 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-04 | 183 | 63 | 4 | d1bf3abf42eb9d7facf775becf1338d1faadd647 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 184 | 63 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 184 | 63 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 184 | 63 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Serous|World / shred by cell class for bronchial biopsy | 1.34e-04 | 184 | 63 | 4 | 09d0d1525c11dd326efd942684c03f79d992cf3b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 184 | 63 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 184 | 63 | 4 | 7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 184 | 63 | 4 | 53b71c4ac86dc5e42763b8f64fbc917177531017 | |
| ToppCell | facs-Heart-LV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 185 | 63 | 4 | a835f821a5e6568d648df831ec4c2d0048d67093 | |
| ToppCell | facs-Heart-LV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 185 | 63 | 4 | 386b08bcb304db543e3c5ff75f85e99bf0c592df | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 185 | 63 | 4 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 186 | 63 | 4 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 186 | 63 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 186 | 63 | 4 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | CF-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 1.42e-04 | 187 | 63 | 4 | adc79e5804ab98006dbdf1d76ef0d8f85cc5cb0f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 188 | 63 | 4 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.45e-04 | 188 | 63 | 4 | 5d12afb483d028ca02b3b4215131f6128e8bcd48 | |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-04 | 191 | 63 | 4 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 191 | 63 | 4 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|(1)_Control_(PBS) / Stress and Cell class | 1.57e-04 | 192 | 63 | 4 | 40f380f5f0bed63a7404be050838ebd01ef08987 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 192 | 63 | 4 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 192 | 63 | 4 | 48b69d6f46e583378186d2993a202f9584688bfa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 193 | 63 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 193 | 63 | 4 | 56145861ef5e7655db9ad0d11b82f72dcadf285d | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 193 | 63 | 4 | 3d1710a6060d3a70994a206334ccb16cd63e5f20 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.60e-04 | 193 | 63 | 4 | 3465352298b1fc9d75af4c2fdd91ad7990cbc901 | |
| ToppCell | COPD-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 1.64e-04 | 194 | 63 | 4 | 72a2e0cba171ab59aa176e91a59a54c562af0390 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 194 | 63 | 4 | a0cfc8c1cdc0722db39170e4417615b6e6b85041 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 194 | 63 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 194 | 63 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 194 | 63 | 4 | a8238f312a973cadf6eb29c1e02ba898c0a20412 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 75 | 63 | 3 | 3dac715d3610f3bfa6e65e607562d6560462749e | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 75 | 63 | 3 | 8a0568fca07cf5d1016a04bcc3ba365dd5e53f7a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 75 | 63 | 3 | fc508ffa30ec364949b82b8271b8dc4e67b6a416 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 75 | 63 | 3 | 324d34ae723a462052074f6a2e4f5d21c4c4c00d | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 195 | 63 | 4 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-04 | 196 | 63 | 4 | 5cc14a5797884ff3a007683048e690a0d7172fc4 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-04 | 196 | 63 | 4 | 07e6214e771c65574f0ada65e75f4bda265aa47f | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-04 | 196 | 63 | 4 | 88517bb92be2f05c1e1ad94af22ac10d8c5c13c7 | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-04 | 196 | 63 | 4 | d074c24fecd0e3ffca4699fb1a9d443e6d9a858d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 197 | 63 | 4 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 1.74e-04 | 197 | 63 | 4 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 197 | 63 | 4 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| Drug | L-BMAA | 3.66e-06 | 38 | 63 | 4 | CID000028558 | |
| Drug | DETC-MeSO | 4.07e-06 | 39 | 63 | 4 | CID003035711 | |
| Drug | HA-966 | 4.07e-06 | 39 | 63 | 4 | CID000001232 | |
| Drug | Joro spider toxin | 6.06e-06 | 43 | 63 | 4 | CID000119582 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 7.54e-06 | 2 | 63 | 2 | ctd:C084273 | |
| Drug | 5,7-dichlorokynurenic acid | 1.03e-05 | 49 | 63 | 4 | CID000001779 | |
| Drug | LY354740 | 1.21e-05 | 51 | 63 | 4 | CID000114827 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.56e-05 | 193 | 63 | 6 | 3708_UP | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.65e-05 | 195 | 63 | 6 | 3268_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.75e-05 | 197 | 63 | 6 | 4729_UP | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.86e-05 | 199 | 63 | 6 | 5542_UP | |
| Drug | GYKI 52466 | 2.02e-05 | 58 | 63 | 4 | CID000003538 | |
| Drug | YM90K | 3.44e-05 | 23 | 63 | 3 | CID005486547 | |
| Drug | L-Glutamic Acid | 3.80e-05 | 68 | 63 | 4 | DB00142 | |
| Drug | CGP 39653 | 3.92e-05 | 24 | 63 | 3 | CID006437837 | |
| Drug | felbamate | 4.26e-05 | 70 | 63 | 4 | CID000003331 | |
| Drug | gavestinel | 4.45e-05 | 25 | 63 | 3 | CID006450546 | |
| Drug | AC1L1DME | 5.58e-05 | 75 | 63 | 4 | CID000002414 | |
| Drug | L-689,560 | 5.63e-05 | 27 | 63 | 3 | CID000121918 | |
| Drug | aptiganel | 6.30e-05 | 28 | 63 | 3 | CID000060839 | |
| Drug | C-PP | 6.30e-05 | 28 | 63 | 3 | CID000001228 | |
| Drug | AC1NUW3V | 7.01e-05 | 29 | 63 | 3 | CID005462126 | |
| Drug | ketobemidone | 7.01e-05 | 29 | 63 | 3 | CID000010101 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 7.77e-05 | 30 | 63 | 3 | CID000001226 | |
| Drug | AC1L32TU | 7.77e-05 | 30 | 63 | 3 | CID000107831 | |
| Drug | GYKI 53655 | 7.77e-05 | 30 | 63 | 3 | CID000126757 | |
| Drug | uranyl acetate | 7.90e-05 | 258 | 63 | 6 | ctd:C005460 | |
| Drug | LY235959 | 8.59e-05 | 31 | 63 | 3 | CID000131938 | |
| Drug | NPC 12626 | 8.59e-05 | 31 | 63 | 3 | CID000108099 | |
| Drug | eliprodil | 8.59e-05 | 31 | 63 | 3 | CID000060703 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 9.46e-05 | 32 | 63 | 3 | CID000001222 | |
| Drug | memantine | 9.54e-05 | 86 | 63 | 4 | CID000004054 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 1.04e-04 | 33 | 63 | 3 | CID000002071 | |
| Drug | wyosine | 1.12e-04 | 6 | 63 | 2 | CID000171185 | |
| Drug | D-CPPene | 1.14e-04 | 34 | 63 | 3 | CID006435801 | |
| Drug | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid | 1.24e-04 | 35 | 63 | 3 | ctd:C520612 | |
| Drug | Glutathione | 1.35e-04 | 36 | 63 | 3 | DB00143 | |
| Drug | gacyclidine | 1.35e-04 | 36 | 63 | 3 | CID000176265 | |
| Drug | R,S)-AMPA | 1.35e-04 | 36 | 63 | 3 | CID000001221 | |
| Drug | C6H12NO5P | 1.35e-04 | 36 | 63 | 3 | CID000104962 | |
| Drug | glutamic acid diethyl ester | 1.35e-04 | 36 | 63 | 3 | CID000073960 | |
| Drug | CGS 19755 | 1.59e-04 | 38 | 63 | 3 | CID000068736 | |
| Drug | 4CPG | 1.59e-04 | 38 | 63 | 3 | CID000005115 | |
| Drug | Uranium | 1.67e-04 | 296 | 63 | 6 | ctd:D014501 | |
| Drug | Pyridostigmine Bromide | 1.71e-04 | 100 | 63 | 4 | ctd:D011729 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.91e-04 | 192 | 63 | 5 | 5567_UP | |
| Drug | cyclothiazide | 1.92e-04 | 103 | 63 | 4 | CID000002910 | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 63 | 5 | 3245_UP | |
| Drug | 4-nitrophenyl-N-acetyl-beta-D-glucosaminide | 2.09e-04 | 8 | 63 | 2 | CID000082398 | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 2295_UP | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 4697_DN | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; HL60; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 2741_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 4587_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 1499_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 3743_UP | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 4428_UP | |
| Drug | racemethorphan | 2.22e-04 | 107 | 63 | 4 | CID000003008 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 2329_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 5426_UP | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HG-U133A | 2.26e-04 | 199 | 63 | 5 | 1889_DN | |
| Drug | kynurenine | 2.30e-04 | 108 | 63 | 4 | CID000000846 | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.31e-04 | 200 | 63 | 5 | 5601_UP | |
| Drug | wortmannin; Up 200; 0.01uM; SKMEL5; HG-U133A | 2.31e-04 | 200 | 63 | 5 | 506_UP | |
| Drug | 7-chlorokynurenic acid | 2.64e-04 | 45 | 63 | 3 | CID000001884 | |
| Drug | 1m5b | 2.68e-04 | 9 | 63 | 2 | CID000447081 | |
| Drug | LY339434 | 2.68e-04 | 9 | 63 | 2 | CID006324635 | |
| Drug | ferrous oxalate dihydrate | 2.68e-04 | 9 | 63 | 2 | CID000516788 | |
| Disease | Schizophrenia | NPTN MAOA APC GRB2 ARC KDM2B GRID1 GRIK1 GRIK2 OPA1 ADCYAP1R1 | 1.73e-06 | 883 | 61 | 11 | C0036341 |
| Disease | body mass index, fasting blood glucose measurement | 1.63e-04 | 51 | 61 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | Colorectal Neoplasms | 2.72e-04 | 277 | 61 | 5 | C0009404 | |
| Disease | Endometrioma | 3.50e-04 | 161 | 61 | 4 | C0269102 | |
| Disease | Endometriosis | 3.50e-04 | 161 | 61 | 4 | C0014175 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 5.60e-04 | 17 | 61 | 2 | EFO_0021049 | |
| Disease | Colorectal Carcinoma | 5.99e-04 | 702 | 61 | 7 | C0009402 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 7.80e-04 | 20 | 61 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | 9.51e-04 | 550 | 61 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | phosphatidylserines measurement | 1.03e-03 | 23 | 61 | 2 | EFO_0020049 | |
| Disease | ceramide measurement | 1.43e-03 | 235 | 61 | 4 | EFO_0010222 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.53e-03 | 28 | 61 | 2 | DOID:3717 (is_marker_for) | |
| Disease | neuroimaging measurement | 1.55e-03 | 1069 | 61 | 8 | EFO_0004346 | |
| Disease | Carcinoma, Granular Cell | 1.80e-03 | 116 | 61 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.80e-03 | 116 | 61 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.80e-03 | 116 | 61 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.80e-03 | 116 | 61 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.80e-03 | 116 | 61 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.80e-03 | 116 | 61 | 3 | C0001418 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QIQNHMNGPAKKWWE | 241 | Q7LC44 | |
| LHMMKEKWWRGNGCP | 806 | P39086 | |
| WEPMKVHDIRWNFEK | 171 | P22352 | |
| GEKLNHWKWGDMRQP | 211 | Q96IZ2 | |
| AQWLKHNKFGGAMVW | 346 | Q9BZP6 | |
| HSDPVWQVKWQKDDM | 431 | Q9UI46 | |
| KKMAQWRHGSWTPCS | 1151 | P59510 | |
| IPWMHAARHGWDVEK | 36 | P14316 | |
| WQPHSSKQDDMWEHI | 466 | Q96RS6 | |
| DAPWEAQHADKWDKM | 141 | P21397 | |
| ESHMQWAWGRLPKVA | 241 | Q9BQK8 | |
| KRDWGHAKDYVEAMW | 246 | O60547 | |
| DMDILKHKWWPKNGQ | 796 | O43424 | |
| HDPHGQVIWGMSWAK | 261 | Q8N4B4 | |
| AGVATWPWDKEALMH | 526 | Q13219 | |
| MDNSDPNWWKGACHG | 186 | P62993 | |
| WEAKEKQDWHMCPNI | 901 | Q969R2 | |
| GMWDNITCWKPAHVG | 56 | P41586 | |
| KMAPVEWWKGHETLR | 3651 | Q5VST9 | |
| LVWMAIGHQGDHWKE | 751 | O14786 | |
| NAIENMVGPDWKKRW | 761 | O60313 | |
| HQMPCKWGWALALTN | 451 | Q9BTY2 | |
| VDWVDNMWPQHLKEK | 196 | Q8NHM5 | |
| KWMNWKHLKEDGFPS | 356 | Q86Z20 | |
| NDWHDSQEKPAMEKW | 5381 | Q9Y6R7 | |
| PADMDKAWWKSFLNH | 21 | Q9BQM9 | |
| IGHLKGAPASWWNHM | 201 | O60427 | |
| DLQGMKWAKNWVLEP | 271 | O00292 | |
| KCSMGFHAGWEQPHW | 481 | Q9UI17 | |
| DLDVLKQKWWPHMGR | 796 | Q9ULK0 | |
| KQKWWPHMGRCDLTS | 801 | Q9ULK0 | |
| MSHWAPEWKRAEANP | 1 | Q86TM3 | |
| LHMMKEKWWRGNGCP | 791 | Q13002 | |
| NGDDAHPLWKWMKIQ | 136 | P36969 | |
| WEPMKVHDIRWNFEK | 171 | P59796 | |
| KPMWEDDANKNGGKW | 121 | O60573 | |
| GWLMGVKESDWNQHK | 561 | O00499 | |
| CPWKIGKMETWLHEQ | 236 | Q9NVL8 | |
| HVGITWWAPKVKAEM | 131 | Q9BPU6 | |
| IHSNKPALWIMAAKW | 136 | Q9NYH9 | |
| IDPNAKGWMDWAAHK | 171 | Q9UN36 | |
| KGWMDWAAHKLTGLT | 176 | Q9UN36 | |
| DWMVHHFWRKGKDPD | 521 | Q96JW4 | |
| PLEHAWMLSASDGKW | 266 | Q53LP3 | |
| WHLWNRMMEPAGEKD | 306 | Q6P1J6 | |
| WKHKMLEWDLEVQAG | 2616 | Q9NRC6 | |
| ALDTGWNELHKMWEN | 1146 | Q01082 | |
| PHWLDKWMLTRKQFG | 151 | Q9UHE8 | |
| WQWFDGVMEVLKKHH | 571 | P42229 | |
| WEWQEAHEPGMDQDK | 421 | P25054 | |
| WRMFQKWIKAGDHSE | 201 | Q9UGN4 | |
| SKWEPVKWENDMHCA | 956 | Q9BXT8 | |
| NWPEWMKGHHVNITK | 1236 | Q8N2C7 | |
| KSMKGCEHGWWEINE | 421 | Q7RTY8 | |
| GSKVKDMAGDWHWAL | 206 | Q9H2V7 | |
| HPDWIWRKKENGMPM | 266 | Q9Y639 | |
| AGDDMLLKHRKEFWW | 371 | P52849 | |
| EALEWAMKNHLWGHA | 456 | Q96JE7 | |
| KASNGWMALDWAKHF | 536 | Q9H6S0 | |
| VGKNVDKWLWMLGAH | 191 | Q9NV66 | |
| VWDMKWAKDNPDLFA | 596 | Q9P2L0 | |
| MGSTKHWGEWLLNLK | 1 | Q9H3S5 | |
| NVKDWMDPSEAWANA | 1761 | P01266 | |
| HGEMKFQWDLNAWTK | 386 | Q13263 | |
| LDVWWEVMKHKGHPQ | 161 | P57678 |